Bristol-Myers Squibb Co. Chief Executive Giovanni Caforio is planning to retire, the company said Wednesday.
Chief Commercialization Officer Christopher Boerner will take the helm when Dr. Caforio leaves his position Nov. 1, the company said. Dr. Caforio will remain executive chairman of the drugmaker.